Hyaluronic acid (sodium), CAS [[9067-32-7]]

Artikelnummer: MCE-HY-B0633
Artikelname: Hyaluronic acid (sodium), CAS [[9067-32-7]]
Artikelnummer: MCE-HY-B0633
Hersteller Artikelnummer: HY-B0633
Alternativnummer: MCE-HY-B0633-1G,MCE-HY-B0633-50MG,MCE-HY-B0633-500MG,MCE-HY-B0633-25G,MCE-HY-B0633-5G,MCE-HY-B0633-100MG,MCE-HY-B0633-10G
Hersteller: MedchemExpress
Kategorie: Biochemikalien
Alternative Synonym: Sodium hyaluronate
Hyaluronic acid sodium (Sodium hyaluronate) is a biopolymer composed of repeating units of disaccharides with various applications. Hyaluronic acid sodium is a major component of the extracellular matrix (ECM). Hyaluronic acid sodium is synthesized at the plasma membrane. Increased hyaluronic acid sodium levels are associated with tumor cell growth, adhesion, migration, invasion and angiogenesis in digestive cancers. Hyaluronic acid sodium participates in tissue remodeling and rapid cell proliferation in some physiological processes including embryonic morphogenesis and wound-healing. Hyaluronic acid sodium activates the PI3K-Akt signaling. Hyaluronic acid sodium acts as a regulator of cancer-associated lymphangiogenesis. Hyaluronic acid sodium also enhances cell invasion and angiogenesis by promoting proteolytic MMP-9 binding to cell surface or stimulating MMP-9 binding to cell surface. Hyaluronic acid sodium can be used as drug delivery for sodium butyrate to improve the anti-proliferative activity on breast cancer cell line. Hyaluronic acid sodium can be studied in joint diseases, wound healing and cancer[1][2][3][4][5].
Molekulargewicht: 1500 (kDa)
Reinheit: 98
CAS Nummer: [9067-32-7]
Target-Kategorie: Akt,Bacterial,Endogenous Metabolite,PI3K
Anwendungsbeschreibung: MCE Product type: Natural Products